Dr. Minesh Mehta, MD
Claim this profileMiami Cancer Institute
Studies Meningioma
Studies Brain Tumor
5 reported clinical trials
10 drugs studied
Affiliated Hospitals
Clinical Trials Minesh Mehta, MD is currently running
Radiation Therapy vs Observation
for Meningioma
This trial studies if radiation therapy helps prevent the return of grade II meningioma after surgery. Radiation therapy uses powerful x-rays to destroy any leftover cancer cells. The goal is to see if this improves patient outcomes compared to just monitoring them. Radiation therapy has shown success in stabilizing tumor growth and reducing recurrence risk.
Recruiting2 awards Phase 312 criteria
Electric Field Therapy + Bevacizumab
for Meningioma
The purpose of this research study is to determine the effects bevacizumab (the study drug) combined with Optune (the study device) tumor treatment field therapy has on meningiomas. Bevacizumab is considered investigational because the US Food and Drug Administration (FDA) has not approved its use for the treatment of meningiomas. The study drug is a medication that blocks the growth of new blood vessels. It is thought that the study drug may interfere with the growth of new blood vessels and therefore might stop tumor growth, and possibly shrink the tumor by keeping it from receiving nutrients and oxygen supplied by the blood vessels. Optune is also considered investigational because the US FDA has not approved its use for the treatment of meningiomas. Optune is a device that the patient will wear and use for at least 18 hours of each day. It delivers alternating electrical current to the patient's brain tumor and by doing so interrupts a process called mitosis. Mitosis needs to occur in order for cell division to occur and allows tumors to grow. By slowing this process, we hypothesize that meningioma growth may also be slowed.
Recruiting1 award Phase 212 criteria
More about Minesh Mehta, MD
Clinical Trial Related4 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Minesh Mehta, MD has experience with
- Clinical Observation
- Radiation Therapy
- Hippocampal Avoidance
- Whole-Brain Radiation Therapy
- High Dose Radiation 100 CGy
- Low Dose Radiation 35 CGy
Breakdown of trials Minesh Mehta, MD has run
Meningioma
Brain Tumor
Lung Cancer
Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Minesh Mehta, MD specialize in?
Minesh Mehta, MD focuses on Meningioma and Brain Tumor. In particular, much of their work with Meningioma has involved treating patients, or patients who are undergoing treatment.
Is Minesh Mehta, MD currently recruiting for clinical trials?
Yes, Minesh Mehta, MD is currently recruiting for 2 clinical trials in Miami Florida. If you're interested in participating, you should apply.
Are there any treatments that Minesh Mehta, MD has studied deeply?
Yes, Minesh Mehta, MD has studied treatments such as Clinical Observation, Radiation Therapy, Hippocampal Avoidance.
What is the best way to schedule an appointment with Minesh Mehta, MD?
Apply for one of the trials that Minesh Mehta, MD is conducting.
What is the office address of Minesh Mehta, MD?
The office of Minesh Mehta, MD is located at: Miami Cancer Institute, Miami, Florida 33176 United States. This is the address for their practice at the Miami Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.